Abstract:Background: Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in urinary obstruction in aging men. It comes to more and more patients with massive BPH with the aging of society and extension of life expectancy. Objective: The aim of the study was to compare the clinical efficacy, safety, and complications between transurethral bipolar plasmakinetic enucleation of the prostate (PKEP) and transurethral resection of the prostate (TURP) in the treatment of massive BPH. Design and setting: Patients with BPH were divided into the PKEP group and the TURP group randomly. Intraoperative blood loss (BL), operation time (OT), resected tissue weight (RTW), gland resection ratio (GRR), postoperative indwelling ureter time (IUT), bladder fistula time (BFT) and hospital stay time (HST), preoperative and postoperative serum sodium concentration (SSC), hemoglobin concentration (HGB), prostate weight (PW), postvoid residual (PVR), maximum urinary flow rate (Qmax), international prostate symptom score (IPSS), quality of life (QOL), International Index of Erectile Function (IIEF), and other complications were analyzed and compared respectively. Results: There was no statistical difference in preoperative IPSS, preoperative QOL score, preoperative PVR, preoperative Qmax, postoperative QOL score, postoperative PVR, postoperative Qmax, IPSS difference value (DV), Qmax DV, and PVR DV between the PKEP group and the TURP group (p > 0.05). OT, BL, IUT, BFT, HST, and postoperative IPSS in the PKEP group were significantly lower than that in the TURP group (p < 0.01). RTW and GRR in the PKEP group were significantly higher than that in the TURP group (p < 0.01). QOL DV in the PKEP group was higher than that in the TURP group (p < 0.05). There was statistical difference in SSC DV between the PKEP group and the TURP group (p < 0.05). There was significant statistical difference in postoperative PW, postoperative HGB, PW DV, and HGB DV between the PKEP group and the TURP group (p < 0.01). There was significant statistical difference in IPSS, QOL, PVR, and Qmax between postoperative value and preoperative value in both groups (p < 0.01). The incidence of transurethral resection syndrome, obturator nerve reflex, transient urinary incontinence, and retrograde ejaculation between the PKEP group and the TURP group has no statistical difference (p > 0.05). Capsule perforation, blood transfusion, secondary hemorrhage, bladder neck contracture, and urethral stricture in the PKEP group were lower than that in the TURP group (p < 0.05). Bladder spasm in the PKEP group was significantly lower than that in the TURP group (p < 0.01). There was no statistical difference in preoperative and postoperative IIEF-5, effective erectile frequency, telotism average tension, sustainable telotism average time, and sexual dissatisfaction between the PKEP group and the TURP group (p > 0.05). Conclusions: PKEP and TURP have similar clinical efficacy in the treatment of massive BPH. PKEP has advantages in shorter OT, less BL, more GRR, and fewer complications, but the long-term therapeutic effect of PKEP needs further follow-up.

Clinical Observation of Plasma Kinetic Resection of Prostate Combined with Endocrine Therapy in the Treatment of Advanced Prostate Cancer with Bladder Outlet Obstruction

Management of Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

Comparison of efficacy and safety between transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics

Adjuvant Hormone Therapy after Radical Prostatectomy in High-Risk Localized and Locally Advanced Prostate Cancer: First Multicenter, Observational Study in China

The preliminary study of radiofrequency ablation in combination with hormonal therapy for the treatment of intermediate and advanced prostate cancer

Comparative Study of the Effectiveness and Safety of Transurethral Bipolar Plasmakinetic Enucleation of the Prostate and Transurethral Bipolar Plasmakinetic Resection of the Prostate for Massive Benign Prostate Hyperplasia (>80 ml)

A comparative study on the efficacy and safety of modified plasma kinetic resection of the prostate and transurethral resection of the prostate in the treatment of benign prostatic hyperplasia

Clinical Efficacy of TKRP Surgery and Its Effect on Serum PSA Level for Treating the Patients with Benign Prostatic Hyperplasia

Two-year Outcome of High-risk Benign Prostate Hyperplasia Patients Treated with Transurethral Prostate Resection by Plasmakinetic or Conventional Procedure

An evaluation of transurethral plasma kinetic resection versus transurethral resection of the prostate for the treatment of symptomatic BPH

Diagnosis and treatment of advanced prostatic cancer(report of 84 cases)

Clinical efficacy of neoadjuvant chemohormonal therapy combined with laparoscopic radical prostatectomy in high-risk Prostate Cancer

Clinical Analysis of Prostate Cancer with Bone Metastasis: A Report of 63 Cases

Impact of Plasmakinetic Resection of Prostate on Sexual Function in Patients with Benign Prostatic Hyperplasia

Radical Prostatectomy Plus Extended Lymph Node Dissection for Locally Advanced Prostate Cancer: 12-Year Experience of a Single Centre

Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia

Efficacy and Safety of Bipolar Plasma Vaporization of the Prostate with "Button-Type" Electrode Compared with Transurethral Resection of Prostate for Benign Prostatic Hyperplasia.

[TURP plus endocrine therapy (ET) versus α1A-blockers plus ET for bladder outlet obstruction in advanced prostate cancer]

[Clinical Outcomes of Laparoscopic Radical Prostatectomy for High Risk Prostate Cancer].

Endourological treatment for benign prostate hyperplasia in elderly high-risk patients